Page 147 - CW E-Magazine (12-12-2023)

Pharmaceuticals Hydrocarbons

POOLING RESOURCES GAS IMPORTS
Bharat Biotech, University of Sydney join hands for HPCL to commission Chhara LNG terminal in 2-3

vaccine research months

Hindustan Petroleum Corporation
Bharat Biotech International Ltd. in a release. “Mutually, we are excited loping novel vaccines to eradicate human
(BBIL) and the University of Sydney about the new opportunities to strengthen and animal diseases that are safe, Ltd. (HPCL) plans to start operations at
its 5-mtpa Chhara LNG import terminal
Infectious Diseases Institute (Sydney ID) our shared vision, leverage the prowess affordable, and effective cannot be over- in Gujarat in the next couple of months
have inked a Memorandum of of education, and research capabilities stated. “Together with Bharat Biotech and has already got offers from 6-7 par-
Understanding (MoU) to advance to help build a healthier universe, and International Limited, we aim to make a ties to hire capacity, a senior company
vaccine research initiatives. It will also improve people’s lives by developing lasting impact on global health,” he said. offi cial has said.
strengthen academic-industry partner- safer vaccine platforms,” he added.
ships and augment global efforts to The pact aims to build strong sec- The terminal was mechanically
combat infectious diseases. The collaboration would also help toral and cross-organisational colla- completed in March, but its commis-
build the talent of young scientists with borations to design novel methodologies
“This agreement refl ects our ethos a passion to innovate, Dr. Ella said. to tackle future epidemics and infec- sioning was delayed as a 40-km pipe-
to facilitate collaborative research, fos- tious diseases. Furthermore, it aims to line connecting it to an existing net-
work meant for sales to consumers was as feedstock. The gas can be used to economy expands, there will be space
ter innovation, and further advance the According to Mr. Jamie Triccas, leverage academia-industry strengths not yet ready. make fertilizer, generate power, pro- for all fuels, both conventional fos-
science of vaccine technology,” Dr. Krishna Deputy Director at Sydney ID, the repu- for advancing the science of vaccines duce chemicals or be converted into sil fuels and cleaner alternate ones, to
Ella, Executive Chairman, BBIL, said tational and societal impacts of deve- and biotherapeutics. “We will commission the LNG ter- CNG to run automobiles or piped to grow,” he said, adding HPCL would
Strides executes fi nal agreements for transfer minal in the next couple of months,” household kitchens for cooking. add petrol pumps in unserved areas.
This addition would continue for the
HPCL Director (Marketing), Mr. Amit
of Bengaluru facility to Syngene Garg, said. Expanding retail business next 2-3 years, he said.
HPCL will also continue to invest
Stelis Biopharma, a subsidiary certain post-closing actions and fi nal Pharma Science and Amneal Pharma- HPCL is a late entrant into the LNG in expanding its traditional fuel retail- HPCL will also build on the infra-
of Strides Pharma Science, has adjustments, if any, in the month. ceuticals, Inc. have announced the business. It built the facility at Chhara ing business, and plans to add 1,000 structure for alternate fuels. It plans
announced closure of its transaction addition of icosapent ethyl acid soft in Gir-Somnath district of Gujarat petrol pumps every year to its network to double the number of EV charging
with Syngene International to trans- The proceeds received, along gel capsules ot its portfolio. The pro- to receive natural gas that has been of about 21,500 stations. stations to 5,000 in the next two years,
fer its Unit 3 multi-modal facility in with cash and cash equivalents, has duct has been in-licensed from Strides, supercooled to a liquid state in cryogenic and is setting up stations that can fuel
Bengaluru to Syngene at a gross consi- been deployed to repay Stelis’ lenders and will be commercialized by Amneal ships. At the terminal, the liquid gas “India is a growing market where LNG-powered trucks and buses, while
deration adjusted from Rs. 702-crore to Rs. 420-crore, Strides Pharma Science starting in the fourth quarter of 2023. will again be turned into gaseous state per capita energy consumption is way its retail network also expands CNG
Rs. 617-crore. said. before being piped to industries for use below the world average. And as the dispensing capacity.
The drug is indicated as an adjunct CBG PLANT
On December 1, Stelis received Launches icosapent ethyl acid soft to diet to reduce triglyceride levels
Rs. 395-crore and the remaining amount gel capsules in adult patients with severe hyper- OIL signs MoU with Rajiv Gandhi Institute of
would be received on completion of In another development, Strides triglyceridemia.
Zydus Life bags USFDA nod for heart drug Petroleum Technology
Oil India Ltd. (OIL) and Rajiv The MoU is the fi rst step towards mission to provide green and clean en-
Zydus Lifesciences has received the at the company’s formulation facility in Gandhi Institute of Petroleum Techno- collaboration between OIL and RGIPT ergy under the SATAT scheme. OIL and
fi nal nod from the US FDA for a heart Ahmedabad. logy (RGIPT) have signed a Memo- for land lease and other agreements RGIPT will work towards providing
drug, Ivabradine. randum of Understanding (MoU) on to set up and operate a 5-tpd (tonnes technical and administrative support,
“Zydus was one of the fi rst abbre-
The drug reduces the risk of hospi- viated new drug application (ANDA) a project for the establishment of a per day) CBG plant at the premises of and R&D initiatives within the realm of
talisation in adult patients with reduced applicants to submit a substantially compressed biogas (CBG) plant. Assam Energy Institute (AEI), Sibsagar biogas and its derivatives.
left ventricular ejection fraction, and is complete ANDA with a paragraph IV which is a centre of RGIPT Jais
also used in children aged 6 months and certifi cation for Ivabradine Tablets, 5-mg The MoU was signed by Mr. B.J. (UP). The feedstock proposed for the
older for the treatment of stable sympto- and 7.5-mg and therefore may be Phukan, Managing Director, Numaligarh CBG plant would be a mix of cow
matic heart failure due to cardiomyo- eligible for 180 days of shared generic Refi nery Ltd. (NRL) and Prof. A.S.K. Sinha, This OIL and RGIPT initiative dung, market waste and Municipal Solid
pathy. The drug will be manufactured exclusivity,” said the company. Director, RGIPT recently at Guwahati. aligns with the Government of India’s Waste (MSW).

146 Chemical Weekly December 12, 2023 Chemical Weekly December 12, 2023 147

Contents Index to Advertisers Index to Products Advertised